Pharmaceuticals, Biotechnology and Life Sciences
Company to provide update on status of ongoing Phase 2 clinical trial in eosinophilic asthma PITTSBURGH–(BUSINESS WIRE)–#Knoppbio–Knopp Biosciences LLC, a…
Company to provide update on status of ongoing Phase 2 clinical trial in eosinophilic asthma PITTSBURGH–(BUSINESS WIRE)–#Knoppbio–Knopp Biosciences LLC, a…
DUBLIN–(BUSINESS WIRE)–The “Cubicin – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Cubicin Drug Insight, 2019 highlights the…
DUBLIN–(BUSINESS WIRE)–The “Cubicin – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Cubicin Drug Insight, 2019 highlights the…
DUBLIN–(BUSINESS WIRE)–The “Adlyxin – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Adlyxin Drug Insight, 2019 highlights the…
DUBLIN–(BUSINESS WIRE)–The “Adlyxin – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Adlyxin Drug Insight, 2019 highlights the…
DUBLIN–(BUSINESS WIRE)–The “Rocephin- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Rocephin – Drug Insight, 2019 highlights the…
DUBLIN–(BUSINESS WIRE)–The “Rocephin- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Rocephin – Drug Insight, 2019 highlights the…
BALLERUP, Denmark & CHENGDU, China–(BUSINESS WIRE)–LEO Pharma A/S and HitGen Inc. are pleased to announce that HitGen and LEO Pharma…
Data presented by MD Anderson demonstrates superiority for NBTXR3 activated by radiation therapy and anti-PD-1 in combination versus the radiation…